Healthcare Services

Gastric Cancer Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Gastric Cancer Market Projected To Become By 2030 Based On Its 2026 Valuation?

The gastric cancer market size has seen rapid expansion in recent years. It is anticipated to increase from $3.64 billion in 2025 to $4.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.2%. The historical growth can be attributed to several factors including the high prevalence of helicobacter pylori infection, smoking and dietary risk factors, broader expansion of chemotherapy usage, growth in hospital-based oncology care, and the development of surgical oncology.

The gastric cancer market size is projected to undergo significant expansion in the next few years. It is expected to grow to $7.29 billion in 2030, achieving a compound annual growth rate (CAGR) of 14.8%. This growth during the forecast period can be attributed to progress in immuno-oncology, an increase in precision diagnostics, the emergence of more cancer screening programs, a rising aging population, and the creation of innovative targeted drugs. Major developments anticipated for the forecast period include the increasing adoption of targeted and immunotherapies, a heightened emphasis on early diagnosis and screening, the expansion of personalized cancer treatment strategies, a growing reliance on combination therapy regimens, and enhanced multidisciplinary cancer care models.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20797&type=smp

What Primary Drivers Are Shaping The Development Of The Gastric Cancer Market?

Increasing obesity rates are anticipated to propel the growth of the gastric cancer market going forward. Obesity is a medical condition characterized by excessive body fat accumulation, often defined by a body mass index (BMI) of 30 or higher, which can lead to various health problems. Factors contributing to rising obesity rates include poor diet, lack of physical activity, sedentary lifestyles, environmental influences, and genetic predispositions. Excess body fat, particularly visceral fat around the abdomen, is associated with a higher risk of developing gastric cancer, as obesity triggers chronic inflammation and metabolic disturbances, both linked to cancer development, contributing to a rise in the demand for gastric cancer treatment. For instance, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that one in eight people worldwide now live with obesity, exceeding 1 billion individuals. Therefore, the rising obesity rates are driving the gastric cancer market.

What Segment Groups Are Identified Within The Gastric Cancer Market?

The gastric cancer market covered in this report is segmented –

1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types

2) By Diagnosis: Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis

3) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments

4) By Distribution Channel: Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By Adenocarcinoma: Intestinal Type Adenocarcinoma, Diffuse Type Adenocarcinoma, Mixed Type Adenocarcinoma

2) By Lymphoma: Primary Gastric Lymphoma, Secondary Gastric Lymphoma

3) By Gastrointestinal Stromal Tumor (GIST): Primary GIST, Metastatic GIST

4) By Carcinoid Tumor: Gastric Carcinoid Type 1, Gastric Carcinoid Type 2, Gastric Carcinoid Type 3

5) By Other Types: Small Cell Carcinoma, Squamous Cell Carcinoma, Mixed Tumors

What Major Market Trends Are Driving Changes In The Gastric Cancer Market?

Leading firms in the gastric cancer market are directing their efforts towards creating advanced technological solutions, including companion diagnostic assays, with the aim of delivering personalized treatment. Such an assay serves as a diagnostic tool to pinpoint individuals who would most effectively respond to a particular therapeutic regimen, determined by the detection of specific biomarkers. An example of this is the U.S. Food and Drug Administration (FDA) approval, announced in October 2024 by F. Hoffmann-La Roche Ltd., a Switzerland-based pharmaceutical company, for its VENTANA CLDN18 (43-14A) RxDx Assay. This assay represents the inaugural immunohistochemistry (IHC) companion diagnostic designed for evaluating CLDN18 protein expression in cases of gastric and gastroesophageal junction (GEJ) adenocarcinoma. Its function is to identify patients who qualify for targeted treatment using VYLOY (zolbetuximab) through the precise measurement of CLDN18 protein variants, with a primary focus on CLDN18. 2. By employing the OptiView DAB IHC Detection Kit on the BenchMark ULTRA instrument, this test significantly contributes to advancing personalized healthcare, thereby broadening the available treatment options for both gastric and GEJ adenocarcinoma.

Which Companies Hold Significant Positions In The Gastric Cancer Market?

Major companies operating in the gastric cancer market are F. Hoffmann La Roche Ltd., Merck And Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Taiho Oncology Inc., Taiho Pharmaceuticals Co. Ltd., Boehringer Ingelheim, Biocon Limited, Jiangsu Hengrui Medicine Co Ltd, BeiGene Ltd

Read the full gastric cancer market report here:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-global-market-report

How Does The Gastric Cancer Market Perform Across Major Global Regions?

North America was the largest region in the gastric cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gastric Cancer Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20797&type=smp

Browse Through More Reports Similar to the Global Gastric Cancer Market 2026, By The Business Research Company

Kernicterus Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/kernicterus-treatment-global-market-report

Rare Neurological Disease Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report

Zollinger Ellison Syndrome Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/zollinger-ellison-syndrome-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795